Guilin Sanjin Pharmaceutical Co Ltd (002275) — Free Cash Flow Generation Index
Guilin Sanjin Pharmaceutical Co Ltd (002275) has a Free Cash Flow Generation Index of -0.06x as of September 2025. Free cash flow of CN¥-6.63 Million represents 0% of operating cash flow (CN¥117.62 Million). See working capital position of Guilin Sanjin Pharmaceutical Co Ltd to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Guilin Sanjin Pharmaceutical Co Ltd Free Cash Flow Generation Index (2006–2024)
Historical FCF Generation Index trend for Guilin Sanjin Pharmaceutical Co Ltd across 19 annual periods. Explore Guilin Sanjin Pharmaceutical Co Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Guilin Sanjin Pharmaceutical Co Ltd (2006–2024)
Year-by-year Free Cash Flow Generation Index for Guilin Sanjin Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see Guilin Sanjin Pharmaceutical Co Ltd (002275) total market value.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.86x | CN¥506.16 Million | CN¥588.33 Million | CN¥82.18 Million | ▼ -0.1% |
| 2023 | 0.86x | CN¥472.85 Million | CN¥549.25 Million | CN¥76.40 Million | ▼ -2.4% |
| 2022 | 0.88x | CN¥466.40 Million | CN¥528.67 Million | CN¥62.27 Million | ▲ +36.0% |
| 2021 | 0.65x | CN¥266.15 Million | CN¥410.24 Million | CN¥144.09 Million | ▼ -1.2% |
| 2020 | 0.66x | CN¥392.52 Million | CN¥597.99 Million | CN¥205.47 Million | ▲ +26.9% |
| 2019 | 0.52x | CN¥242.14 Million | CN¥468.29 Million | CN¥226.14 Million | ▼ -38.2% |
| 2018 | 0.84x | CN¥461.76 Million | CN¥551.73 Million | CN¥89.96 Million | ▼ -0.5% |
| 2017 | 0.84x | CN¥326.29 Million | CN¥387.82 Million | CN¥61.53 Million | ▼ -4.2% |
| 2016 | 0.88x | CN¥471.49 Million | CN¥536.85 Million | CN¥65.36 Million | ▲ +28.0% |
| 2015 | 0.69x | CN¥273.48 Million | CN¥398.50 Million | CN¥125.02 Million | ▲ +46.9% |
| 2014 | 0.47x | CN¥185.25 Million | CN¥396.53 Million | CN¥211.28 Million | ▲ +11069.8% |
| 2013 | 0.00x | CN¥1.31 Million | CN¥314.16 Million | CN¥312.85 Million | ▼ -98.7% |
| 2012 | 0.32x | CN¥96.96 Million | CN¥302.59 Million | CN¥205.63 Million | ▼ -49.0% |
| 2011 | 0.63x | CN¥214.30 Million | CN¥341.05 Million | CN¥126.75 Million | ▼ -4.1% |
| 2010 | 0.66x | CN¥187.05 Million | CN¥285.49 Million | CN¥98.44 Million | ▼ -22.9% |
| 2009 | 0.85x | CN¥308.61 Million | CN¥363.29 Million | CN¥54.68 Million | ▲ +6.5% |
| 2008 | 0.80x | CN¥152.33 Million | CN¥190.97 Million | CN¥38.64 Million | ▼ -10.7% |
| 2007 | 0.89x | CN¥146.80 Million | CN¥164.39 Million | CN¥17.59 Million | ▲ +3.1% |
| 2006 | 0.87x | CN¥188.51 Million | CN¥217.67 Million | CN¥29.16 Million | — |